Trials / Completed
CompletedNCT05791565
Green (Sustainable) VENTOLIN - Pharmacokinetics (PK) Study in Healthy Participants
A Single Dose Two-way Cross-over Study in Healthy Participants to Compare the Pharmacokinetics (PK) of Salbutamol Administered Via Metered Dose Inhalers Containing Propellants HFA-152a and HFA-134a
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study will be conducted to compare the PK of salbutamol administered via metered dose inhalers (MDI) containing propellants 1,1-difluroethane (HFA-152a) and 1,1,1,2-tetrafluoroethane (HFA-134a) in healthy participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Salbutamol HFA-152a | Salbutamol HFA-152a will be administered. |
| DRUG | Salbutamol HFA-134a | Salbutamol HFA-134a will be administered. |
Timeline
- Start date
- 2023-04-03
- Primary completion
- 2023-05-21
- Completion
- 2023-05-21
- First posted
- 2023-03-30
- Last updated
- 2024-09-23
- Results posted
- 2024-09-23
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT05791565. Inclusion in this directory is not an endorsement.